tradmap

CNC Centene Corporation

$66.54 -2.80%

Data as of close

S&P 500 Companies

Held by SPYVOOIVV

Financial · Hospital & Medical Service Plans

Centene Corporation (CNC) is a financial company in the Hospital & Medical Service Plans industry, with a market capitalization of $32.9 billion. Shares last traded at $66.54, 8.1% below their 52-week high. Over the past year the stock is up 87.8%. CNC trades at a price-to-earnings ratio of 22.56, below the Hospital & Medical Service Plans median of 24.01. Net profit margin is 0.8%, below the peer median of 1.1%. Revenue grew 20.0% year over year.

Market Cap
$32.9B
Shares Out
495.1M
EPS (TTM)
$3.01
P/E (TTM)*
22.56
P/S Ratio
0.18
P/B Ratio
1.48
Dividend / Share
—
Dividend Yield
—
52-Week High
$72.41
52-Week Low
$31.64
Volume (venue)
319,631
Avg Vol (3m, venue)
239,770.619

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
-2.22%
1M
+5.64%
3M
+3.84%
6M
+24.26%
YTD
+61.62%
1Y
+87.81%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
47.10
SMA (50)
$66.12
SMA (200)
$55.43
Price vs SMA50
+0.63%
Price vs SMA200
+20.04%
ATR (14)
$2.64

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$178.9B
Net Income
$1.5B
Gross Margin
9.0%
Operating Margin
0.6%
Net Margin
0.8%
Return on Equity
6.6%
Return on Assets
1.8%
Current Ratio
1.16
Debt / Equity
0.70
Revenue Growth (YoY)
+20.0%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-09-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q3 2026 -$0.14 2026-10-27
Q2 2026 $2.19 2026-07-28
Q1 2026 $3.11 2026-04-28
Q4 2025 (derived) -$2.15 2026-02-17
FY 2025 -$13.53 2026-02-17
Q3 2025 -$13.50 2025-10-29

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Hospital & Medical Service Plans peers

CNC vs 10 industry peers (Hospital & Medical Service Plans), by market cap. Data as of close

P/E vs peers
22.56 / 24.01 med
-6% discount
P/S vs peers
0.18 / 0.40 med
-54% discount
Net margin vs peers
0.8% / 1.1% med
below median
1–10 of 10
UNHUnitedHealth Group$359.4B25.450.803.1%-1.54%
ELVElevance Health$89.4B17.390.442.5%-1.47%
CICigna$78.0B13.090.282.1%-1.03%
HUMHumana$49.3B43.590.360.8%-0.97%
CNCCentene Corporation$32.9B22.560.180.8%-2.80%
MOHMolina Healthcare, Inc.$10.9B—0.25-0.1%+1.88%
OSCROscar Health, Inc.$9.6B17.370.824.7%+2.11%
CLOVClover Health Investments, Corp. /De$2.3B—0.93-3.5%-3.25%
ALHCAlignment Healthcare, Inc.$1.5B50.480.300.6%-4.32%
TRUPTrupanion, Inc.$1.4B69.490.891.3%+1.99%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.